The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety, tolerability and preliminary efficacy of CAN04, a first in class monoclonal antibody against IL1RAP, in combination with nab-paclitaxel and gemcitabine (NG) in subjects with pancreatic cancer.
 
Ahmad Awada
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Daiichi Sankyo/Lilly; Eisai; Genomic Health; Ipsen; LEO Pharma; Lilly; Merck Serono; MSD; Novartis; Pfizer; Roche
 
Sebastian Ochsenreither
Honoraria - AstraZeneca; BMS; Ipsen; Merck Serono; MSD
Consulting or Advisory Role - Bayer; BMS; Janssen-Cilag; Merck Serono; MSD
Research Funding - BMS
Patents, Royalties, Other Intellectual Property - Cyclin A1 as T-cell target
Travel, Accommodations, Expenses - Merck Serono
 
Rikke Loevendahl Eefsen
No Relationships to Disclose
 
Dirk Arnold
Honoraria - Bayer; Bristol-Myers Squibb; Merck Serono; Merck Sharp and Dome; Roche/Genentech; SERVIER; TERUMO
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bayer; Biocompatibles; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Servier; Terumo
Research Funding - Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche/Genentech
 
Jeffrey Yachnin
No Relationships to Disclose
 
Per Pfeiffer
No Relationships to Disclose
 
Christiane Jungels
Travel, Accommodations, Expenses - Ipsen; PharmaMar
 
Richard Greil
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Merck; MSD; Novartis; Roche; Sandoz; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen; Merck; MSD; Novartis; Roche; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gilead Sciences (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Sandoz (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen-Cilag; MSD; Novartis; Roche
 
Laurids Poulsen
No Relationships to Disclose
 
Eric Van Cutsem
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bayer; Biocartis; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; GlaxoSmithKline; Halozyme; Incyte; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst)
 
Lars Thorsson
Employment - Cantargia AB
Stock and Other Ownership Interests - Cantargia AB
Research Funding - Cantargia AB
 
Christer Svedman
Employment - Genomic Health
Stock and Other Ownership Interests - Adaptimmune; Alnylam; Cantargia AB; Forty Seven; Moderna, CRISPR; Neurocrine Biosciences; TP Therapeutics; Vertex
Consulting or Advisory Role - Cantargia AB; Genentech; PREMIA
Patents, Royalties, Other Intellectual Property - Patents on gene expression algorithm (Genomic Health)
(OPTIONAL) Uncompensated Relationships - CADEX Genomics
 
Ignacio Garcia-Ribas
Employment - Cantargia AB; Takeda
Stock and Other Ownership Interests - Cantargia AB
Consulting or Advisory Role - Shionogi; TFS
 
Joelle Collignon
Consulting or Advisory Role - Bayer (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Roche (Inst); sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen (Inst); Pfizer (Inst); Roche (Inst)